Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06013930 · ClinicalTrials.gov registry record · NA
Exploring the Efficacy of Treatments for Anxiety and Depression Among College Students
A NA study, sponsored by University of South Dakota.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT06013930: Completed NA study, sponsored by University of South Dakota.
NCT06013930 is a NA study that has completed, run by University of South Dakota. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06013930, a NA study, has completed, sponsored by University of South Dakota.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
The goal of this randomized control group is to learn about effective treatments for college students experiencing anxiety and/or depression. The main questions this clinical trial aims to answer are: 1) Can alternative treatments decrease anxiety and/or depression among college students? 2) Can alternative treatments increase retention rates among college students experiencing anxiety and/or depression? Participants will be randomly assigned to one of three intervention groups: external qigong, mindfulness meditation, or psychoeducation. Researchers will compare outcomes from each group to explore treatment differences.
Primary Outcome
Symptoms of anxiety will be assessed through a trait anxiety assessment (State-Trait-Anxiety Inventory). The range of possible scores spans from a minimum score of 20 to a maximum score of 80 - the higher the score, the higher the symptoms of anxiety.
Interventions
- OTHER Psychoeducation
- BEHAVIORAL Mindfulness Meditation
- BEHAVIORAL External Qigong
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2023-07-25 |
| Est. Completion | 2025-04-15 |
| Phase | NA |
What the finished NCT06013930 record still lists
NCT06013930 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Psychoeducation is the first listed.
NCT06013930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06013930 about?
NCT06013930 is a clinical study titled "Exploring the Efficacy of Treatments for Anxiety and Depression Among College Students". The goal of this randomized control group is to learn about effective treatments for college students experiencing anxiety and/or depression. The main questions this clinical trial aims to answer are: 1) Can alternative treatments decrease anxiety and/or depression among college students? 2) Can alt...
What is the current status of trial NCT06013930?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2023-07-25. Estimated completion is 2025-04-15.
What interventions are being tested in trial NCT06013930?
The interventions under investigation include: Psychoeducation (OTHER), Mindfulness Meditation (BEHAVIORAL), External Qigong (BEHAVIORAL).
Who is sponsoring clinical trial NCT06013930?
This trial is sponsored by University of South Dakota, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06013930's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI